Pulse Biosciences, Inc.
PLSE- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001625101
In the last 90 days, Pulse Biosciences, Inc. insiders filed 2 open-market purchases and 0 sales; 105 institutions reported holding it in 13F filings for Q2 2026, worth $297.0M in total; no superinvestor holds it.
Q1 2023 vs. Q4 2022
How the institutions holding Pulse Biosciences, Inc. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Q1 2023 | Change |
|---|---|---|---|
| Holders | 29 | 27 | −2 |
| Shares | 2.46M | 2.42M | −38.2K (−1.6%) |
| Value | $6.81M | $8.06M | +$1.25M (+18.3%) |
New holders (2)
Institutions that held Pulse Biosciences, Inc. at the end of Q1 2023 but not at the end of Q4 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Spotlight Asset Group, Inc. | 66,425 | $147.0K | 0.15% |
| 25 LLC | 101 | $811 | 0.00% |
Sold out (4)
Institutions that held Pulse Biosciences, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Susquehanna International Group, LLP | 13,650 | $37.8K |
| Simplex Trading, LLC | 9,202 | $25.0K |
| CWM, LLC | 1,050 | $3.00K |
| Tower Research Capital LLC (TRC) | 160 | $0 |